In summary, our study discovered the transcriptional activation of pseudogene UBE2MP1 in HCC and validated the adverse correlation between UBE2MP1 transcript and outcomes in HCC patients. This evidence concerns the gene UBE2MP1 and hepatocellular carcinoma.